At last in Ukraine appeared the long-awaited life-saving antibiotic of the polymyxin group! In the summer of 2008 Delta Medical introduced Colomycin, the main indications for which are serious infections induced by Gr(-) micro organisms.

According to dismal statistics the most frequent cause of death of in-patients are these infections, since their originators are not sensitive to the majority of antibiotics any more. So, the main problem of treatment of serious infections is overcoming resistance of microorganisms to existing antibiotics. Especially dangerous is infection which is caused by the blue purulent bacillus Pseudomonas aeruginosa. Colomycin is the product which is chosen in many countries to treat infections, induced by Pseudomonas aeruginosa.

It is noteworthy that Colomycin has been a life-saving antibiotic for many years all over a world in treatment of respiratory infections.

One of the directions of Delta Medical’s work is thorough study of foreign experience in all spheres of healthcare with the aim of worthy presentation of innovations and achievements of world leaders in pharmaceutical business in the territory of the CIS.

Medical community should get to know about the unique features of the preparations the efficiency of which is reputed all over the world. So, two popular products of Colomycin manufacturer Forest Laboratories Europe (Great Britain) are already known in Ukraine: moms and doctors worthily appraised Sudocrem (for prophylaxis and treatment of diaper dermatitis) and Infacol (is essential for intestinal colics).

These products became well-known thanks to the work of Delta Medical’s therapeutic-pediatric department medical representatives. Such excellent results made it possible for the foreign manufacturer to trust the company with their new products and be certain in the choice of distribution company. Thus, next step in development of relationships between business partners was Colomycin - a modern and original antibiotic. Employing Colomycin doctors can indeed solve the Herculean task of treatment of serious gram-negative infections in day-and-night clinics. The first results raise hopes - all inoculations of the blue purulent bacillus done in the Ukrainian Septic Centre, have shown sensitivity to new antibiotic!

Scientific evidence and clinical practice of Colomycin usage in European countries were presented to the large audience of specialists at the Vth National Convention of Anesthetists (Kiev, 8-12 Sptember, 2008) in the talks of the Director of Ukrainian Sepsis-Centre L.Kharchenko, President of Association of Ukrainian Anesthetists F.Glumcher and academician, professor V.Cherniy. This information was the subject for a long discussion, since the solution to one of the most challenging tasks of treatment of serious infections has been finally found! Such an active discussion assures ones again that Colomycin emerged in the Ukrainian market just in time. This preparation fights for lives of thousands of people abroad! And now, thanks to Delta Medical, Colomycin is available to Ukrainian doctors and patients.

Information:

Delta Medical company was founded in 1999.
There are more than 600 employees in Delta Medical company’s staff.
The partners of Delta Medical include more than 30 world pharmaceutical companies.

Delta Medical
43, Chornovola street, Vyshneve, Ukraine, 08132
tel. + 38 044 593-33-55
fax + 38 044 593-33-54
www.deltamedical.com.ua